Published trade mark details for 2444283
This information was published on 2024-08-12T10:09:22 for IP Right Registration Published.
| Field | Value |
| (210) | 2444283 |
| (220) |
19 Apr 2024
|
| (300) |
US, 04 Jan 2024, 98342071
|
| (511) (510) |
Class 5
Therapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders Class 42 Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology |
| (540) |
|
| (550) | Figurative |
| (730) |
Avidity Biosciences, Inc.
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.